Speaker illustration

Professor Jean-Philippe Empana

National Institute of Health and Medical Research (INSERM home), Paris (France)

Member of:

European Society of Cardiology

Professor Jean-Philippe Empana is an MD, PhD, INSERM Research Director, who is currently co-heading an INSERM team in cardiovascular disease epidemiology at the Paris Cardiovascular Research Centre, Paris, France. He's also an academic chair in Global Health at the Université Paris Cité in the framework of the European Circle U project. Professor Empana has extensive experience in the field of cardiovascular disease risk prediction and the added value of novel biomarkers. Since 2016, he has been coordinating a large research program on the clinical relevance of primordial prevention for the prevention of cardiovascular disease and beyond. Professor Empana is currently coordinating the Paris Prospective Study III, a French community based prospective cohort of 10,000 volunteers with a minimum of 10-year follow-up where he's examining the clinical relevance of vascular aging determined via carotid-echo tracking. Spoken languages spoken: French (native), English, Spanish

Ultra-sensitive troponin-I and incident coronary heart disease, stroke, heart failure, cardiac arrhythmias, arterial aneurysms and venous thromboembolism hospitalizations

Event: ESC Congress 2022

Topic: Biomarkers

Session: Cardiovascular risk assessment - Biomarkers 2

Thumbnail

Association between cardiovascular health and sleep disturbances: results from two population-based cohort studies, the paris prospective study 3 and the colaus study

Event: EuroPrevent 2019

Topic: Sleep Disorders

Session: Risk Factors and Prevention - Sleep Disorders

Thumbnail

Mechanisms of sleep disturbance and cardiovascular risk.

Event: EuroPrevent 2018

Topic: Epidemiology

Session: Sleep as a risk factor for cardiovascular disease

Thumbnail

Impaired baroreflex sensitivity, carotid stiffness and exaggerated exercise blood pressure: a community-based analysis from the paris prospective study 3

Event: ESC CONGRESS 2017

Topic: Haemodynamics, heart and hypertension

Session: Hypertension damage - Under the radar

Thumbnail

ESC 365 is supported by

logo Novo Nordisk